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Tonsillar microbial diversity, abundance, and interrelations in 
atopic and non-atopic individuals
To the Editor,
While the prevalence of allergic diseases has increased worldwide, 
their underlying mechanisms are still not fully understood.1 Tonsils, 
consisting of lymphoid tissue, play an important role in local and 
systemic immune response to bacterial and viral pathogens and al-
lergens.2 Tonsil microbiota is influenced by age and health status.3,4
Allergic diseases, as many other noncommunicable diseases, have 
been associated with imbalance of the gut, respiratory tract, and skin 
microbiotas.1 However, to our knowledge, microbial profiling of tonsils 
comparing atopic and non-atopic subjects has not been performed as 
of yet. Therefore, as tonsillar microbiota can closely modulate immune 
responses and serve as an effective in vivo model in investigating their 
interactions, we wanted to explore whether there are differences in 
bacterial diversity, abundance, and interrelations in tonsils between 
atopic and non-atopic elective tonsillectomy patients.
Human tonsil samples were obtained from two consecutive co-
horts between 2008 and 2015 from Satakunta Central Hospital, Pori, 
Turku University Hospital, Turku, and Salo Regional Hospital, Salo, 
all in Finland.5 Study patients completed a standard questionnaire to 
collect information on health, medication, and respiratory symptoms 
within 30 days before the operation. Tonsillectomy was performed 
by routine clinical practice, and the tonsil samples were stored in 
RNAlater. Blood samples were drawn for allergy tests, and nasopha-
ryngeal aspirate was obtained for respiratory virology analysis. Atopy 
was defined as positive immunoglobulin E antibody (>0.35 kU/L, 
Phadiatop Combi®, Phadia, Uppsala, Sweden) against any of the com-
mon food or aeroallergens. More details in Online Supplementary.
Intratonsillar microbial profiling was performed using RNA se-
quencing data as previously described.6 In total, 53 subjects were 
included consisting of 24 atopics and 29 non-atopics. After filter-
ing out reads mapped to human, the rest were considered microbial 
reads (~1 M reads on average, 6% of total). These candidate microbial 
reads were utilized with Kraken27 for investigating microbial com-
position with default parameters. Phyloseq8 was used to measure 
diversity of microbial communities and EdgeR to assess differential 
abundance in atopic and non-atopic subjects. Differences were con-
sidered significant based on the corrected P value of less than .05. 
Details in Supplementary methods.
The median age of the study subjects was 11 years (range 2-38) 
of which 45% were atopic. All the operations were performed during 
a “cold phase” of chronic tonsil condition. On the operation day, 36 
(68%) had no respiratory tract symptoms, 8 (15%) reported mild re-
spiratory symptoms and 9 (17%) had no data. Main indications for 
tonsillectomy were recurrent tonsillitis (47%) and tonsillar hypertro-
phy (45%), see details in Table S1.
Alpha diversity (measures of richness and species distribution 
in a sample1) was computed to evaluate the difference in micro-
bial diversity between atopic and non-atopic subjects (Figure 1A). 
We observed lower alpha diversity in samples from atopic patients 
compared with non-atopics (P = .02, Figure 1A). After adjusting the 
analysis to age and self-reported allergy, the difference remained 
significant (P = .02). Similar finding was observed when those with 
clinical allergic disease were compared with non-allergic ones (see 
Online Supplementary and Figure S2). To investigate the difference 
in microbial diversity at a group level, we used beta diversity (mea-
sure of diversity between samples). However, β-diversity analysis of 
the tonsillar did not show a significant difference between atopic 
and non-atopic groups (Supplementary results Figure S3).
The most abundant phylum found in microbial data was 
Proteobacteria (Figure 1B). No considerable difference (P = .3) in 
the overall bacterial abundance between atopic and non-atopic 
individuals was observed. However, there was a difference in the 
expression of single pathogens between the study groups. The dif-
ferential abundance of two specific taxa, Clostridium Botulinum and 
Moraxella Osloensis, was lower (unadjusted P < .05, adjusted P < .05) 
in atopic compared with non-atopic study subjects (Figure 1C). 
The heat maps illustrate correlations between the abundances of 
pathogenic bacteria in the two study groups (Figure 2A,B; network 
figures in Figure S4). Positive correlations between pathogenic bac-
teria were stronger in atopic compared with non-atopic individuals 
(Figure 2C).
Our finding of low microbial diversity in tonsils of the atopic pa-
tients is in line with previous studies on other tissues. For example, 
exacerbation of atopic dermatitis has been shown to associate with 
decreased microbial diversity of the skin when compared to healthy 
skin1 and asthma has been linked to imbalance of detrimental and 
beneficial microbes of the respiratory and gastrointestinal epithelium 
when compared to healthy controls.1 Therefore, as tonsil tissue con-
tains rich microbiome, it is logical that atopy status is also associated 
with lower bacterial diversity in tonsils. Collectively, these findings 
suggest that systemic dysbiosis, extending to local lymphoid tissue 
level, is associated with allergic diseases.1 It should be noted, however, 
that our study analyzed gene expression by RNA sequencing whereas 
many earlier studies1 have analyzed DNA and genetic information.
In our study, the most abundant phylum was Proteobacteria and 
the most abundant genera were Salmonella, Klebsiella and Sodalis. 
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This is in line with previous studies, in which Proteobacteria have 
been highly associated with tonsillar hyperplasia and recurrent ton-
sillitis in children.3,4 Also in earlier studies, the increase in Moraxella 
at genus level has been linked to asthma.1 However, in our study, 
the differential abundance of taxa Moraxella Osloensis was lower 
in atopic patients as well as taxa Clostridium Botulinum. Comparing 
the interrelations of pathogenic bacteria, we found more significant 
correlations in the atopic group. The existence of atopy slightly in-
creased the complexity of bacteria-to-bacteria networks. Moreover, 
intra-individual variation of microbiome has been demonstrated 
comparing classical secretory otitis media pathogens in adenoid and 
tonsil tissues.9
This study shows four important findings in elective tonsillec-
tomy patients. First, tonsil tissue contains rich bacterial species in 
direct contact with immune system. Second, this is a first study to 
demonstrate that atopic individuals have lower tonsillar bacterial di-
versity than non-atopics. Third, our data indicate that lower overall 
bacterial abundance and fourth, stronger positive interrelations be-
tween pathogenetic bacteria are associated with atopy. Our study 
provides interesting insights into the microbiome of human tonsils 
and suggests differences in microbial balance between atopic and 
non-atopic subjects. Further studies are warranted to investigate in-
teractions between microbes and lymphoid tissue function.
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F I G U R E  1   Overview of Microbiome data: (A) Atopic subjects (n = 24) had lower microbial alpha diversity than non-atopic subjects 
(n = 29) computed with Chao 1 index (estimate of within-group diversity). Data are shown in mean and SEM. B, At phylum level, atopic 
subjects had a non-significantly lower abundance of Proteobacteria, the largest phylum, than non-atopic subjects (P = .3). C, Of all single 
bacteria, Clostridium botulinum and Moraxella osloensis showed lower abundance in atopic subjects than in non-atopic subjects. Data are 
shown in median, quartiles, and range. Please see the statistics in detail in the Online Supplementary. *P < .05
F I G U R E  2   Heat maps of intratonsillar pathogenic bacteria-to-bacteria interrelations in atopic subjects (A), non-atopic subjects (B) and 
comparison of former two (C). Data show stronger positive interrelations between pathogenetic bacteria in atopic than non-atopic subjects. 
The color scale (blue-red and gray-scale) shows the strength and direction of the correlations. P values < .001, .01, and .05 are indicated with 
***, **, and *, respectively. Please see more details in the Online Supplementary
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